The prognostic factors in cancer patients with the disease in an advanced phase
Bianco, V.; Rozzi, A.; Terenzi, S.; Campisi, C.; Di Domenico, C.
Minerva Medica 90(7-8): 242-244
1999
ISSN/ISBN: 0026-4806 PMID: 10719428 Document Number: 507923
Document emailed within 1 workday
Related Documents
Saisho, T.; Okusaka, T.; Ueno, H.; Morizane, C.; Okada, S. 2005: Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy Hepato-Gastroenterology 52(66): 1654-1658Inaji, H.; Noguchi, S.; Yamamoto, H.; Koyama, H.; Iwanaga, T.; Wada, A. 1989: Analysis of prognostic factors in patients with locally advanced breast cancer treated with intra-arterial infusion chemotherapy as an induction therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Part 2): 2910-2912
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Inal, A.; Kos, F.T.; Algin, E.; Yildiz, R.; Berk, V.; Tugba Unek, I.; Colak, D.; Colak, D.; Kucukoner, M.; Tamer Elkiran, E.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Ali Kaplan, M.; Gok Durnali, A.; Harputoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Gumus, M.; Ozkan, M.; Benekli, M.; Isikdogan, A. 2012: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(1): 102-105
Kim, B.S.; Cho, S.W.; Min, S.K.; Lee, B.H. 2011: Differences in prognostic factors between early and advanced gastric cancer Hepato-Gastroenterology 58: 107-108
Victorzon, M.; Roberts, P.J.; Haglund, C.; von Boguslawsky, K.; Nordling, S. 1997: Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer Anticancer Research 17(4b): 2923-2926
Tural, D.; Kivrak Salim, D.; Mutlu, H.; Erkilic, M.; Gunduz, S.; Karakurt, M.; Musri, F.; Tuna, S.; Boz, A.; Aydin, F.; Karayalcin, B.; Bozcuk, H.; Senol Coskun, H. 2015: Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer? Journal of BUON: Official Journal of the Balkan Union of Oncology 20(5): 1282-1286
Laohavinij, S.; Maneechavakajorn, J. 2004: Prognostic factors for survival in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 87(9): 1056-1064
Prausová, J.; Lohynská, R.; Kubácková, K.; Linke, Z.; Malinová, B.; Kubala, E.; Novotný, J. 2006: Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome Neoplasma 53(3): 263-268
Clement, D.; Miron, L.; Marinca, M. 2007: Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC) Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(4): 856-863
Wagner, T.; Adler, A.; Kubista, E. 1993: S-phase fraction and proportion of cells with high DNA content as prognostic factors of lymph node negative breast cancer Wiener Klinische Wochenschrift 105(24): 712-714
Metindir, J.; Bilir, G. 2007: Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy European Journal of Gynaecological Oncology 28(1): 28-32
Helft, P.R. 2006: An intimate collaboration: prognostic communication with advanced cancer patients Journal of Clinical Ethics 17(2): 110-121
Ettinger, D.S.; Orr, D.W.; Rice, A.P.; Donehower, R.C. 1985: Phase i study of N-methylformamide in patients with advanced cancer Cancer Treatment Reports 69(5): 489-493
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Currie, V.E.; Camacho, F.; Wittes, R.; Young, C. 1980: Phase Ii evaluation of vindesine in patients with advanced breast cancer Cancer Treatment Reports 64(4-5): 693-695
Komuro, Y.; Watanabe, T.; Hosoi, Y.; Matsumoto, Y.; Nakagawa, K.; Suzuki, N.; Nagawa, H. 2005: Prognostic significance of Ku70 protein expression in patients with advanced colorectal cancer Hepato-Gastroenterology 52(64): 995-998
Creagan, E.T.; Nichols, W.C.; O'Fallon, J.R. 1981: Phase Ii evaluation of PALA in patients with advanced head and neck cancer Cancer Treatment Reports 65(9-10): 827-829
Inuyama, Y.; Kida, A.; Tsukuda, M.; Kohno, N.; Satake, B. 2001: Late phase Ii study of S-1 in patients with advanced head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1381-1390
Hu, Y.; Zhong, A.; Yang, X. 2000: Prognostic value of serum CA125 level in patients with advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 22(1): 30-31